| Change Notification | Applies to: * | Date | ||||||
|---|---|---|---|---|---|---|---|---|
| BM-DSG | CB-DSG | GDRI | TD-DSG | TL-DSG | WB-DSG | Red Book | ||
| No. 07 - 2026 Testosterone Replacement Therapy |
⬤ | 17.02.26 | ||||||
| No. 06 - 2026 Transgender and Non-Binary Individuals |
⬤ | 17.02.26 | ||||||
| No. 05 - 2026 Bleeding Disorder |
⬤ | 17.02.26 | ||||||
| No. 04 - 2026 Chapter 3.4: Informed consent |
⬤ | 17.02.26 | ||||||
| No. 03 - 2026 Chapter 23: Specification for the uniform labelling of blood, blood components and blood donor samples |
⬤ | 17.02.26 | ||||||
| No. 02 - 2026 Removal of vCJD risk from component labels |
⬤ | 17.02.26 | ||||||
| No. 01 - 2026 Introduction of seasonal risk for Tropical Viruses |
⬤ | 19.01.26 | ||||||
(*)
BM-DSG - Bone Marrow and Peripheral Blood Stem Cell Donor Selection Guidelines
CB-DSG - Cord Blood Donor Selection Guidelines
GDRI - Geographical Disease Risk Index
TD-DSG - Tissue (Deceased) Donor Selection Guidelines
TL-DSG - Tissue (Live) Donor Selection Guidelines
WB-DSG - Whole Blood and Components Donor Selection Guidelines
Red Book - Guidelines for the Blood Transfusion and Tissue Transplantation Services in the UK